EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Clinical trial NCT03618381 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03618381
Sponsor: Seattle Children's Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Solid Tumor Germ Cell Tumor Retinoblastoma Hepatoblastoma Wilms Tumor Rhabdoid Tumor Carcinoma Osteosarcoma Ewing Sarcoma Rhabdomyosarcoma Synovial Sarcoma Clear Cell Sarcoma

Start date: 2019-06-18
Primary completion: 2040-06-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.